These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24032547)

  • 1. Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Airaksinen JK; Pietilä M; Rivero-Crespo F; Debelder A; Tedjokusumo P; Mikkelsson J; Ylitalo A; Karjalainen PP
    Ann Med; 2013 Nov; 45(7):488-93. PubMed ID: 24032547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Mikkelsson J; Pietilä M; Lalmand J; Rivero-Crespo F; Pentikäinen M; Tedjokusumo P; Karjalainen PP
    Minerva Cardioangiol; 2013 Apr; 61(2):201-9. PubMed ID: 23492603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial.
    Karjalainen PP; Niemelä M; Airaksinen JK; Rivero-Crespo F; Romppanen H; Sia J; Lalmand J; de Bruyne B; Debelder A; Carlier M; Nammas W; Ylitalo A; Hess OM;
    EuroIntervention; 2012 Jul; 8(3):306-15. PubMed ID: 22829506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial.
    Karjalainen PP; Nammas W; Ylitalo A; de Bruyne B; Lalmand J; de Belder A; Rivero-Crespo F; Kervinen K; Airaksinen JKE
    Int J Cardiol; 2016 Nov; 222():275-280. PubMed ID: 27497110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial: Bioactive versus everolimus-eluting stents in elderly patients.
    Nammas W; de Belder A; Niemelä M; Sia J; Romppanen H; Laine M; Karjalainen PP
    Eur J Intern Med; 2017 Jan; 37():43-48. PubMed ID: 27499178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.
    Tuomainen PO; Ylitalo A; Niemelä M; Kervinen K; Pietilä M; Sia J; Nyman K; Nammas W; Airaksinen KE; Karjalainen PP
    Int J Cardiol; 2013 Sep; 168(2):1214-9. PubMed ID: 23218575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome.
    Karjalainen PP; Niemelä M; Pietilä M; Sia J; de Belder A; Rivero-Crespo F; de Bruyne B; Nammas W
    Scand Cardiovasc J; 2016 Aug; 50(4):218-23. PubMed ID: 27102382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.
    Karjalainen P; Kiviniemi TO; Lehtinen T; Nammas W; Ylitalo A; Saraste A; Mikkelsson J; Pietila M; Biancari F; Airaksinen JK
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1693-703. PubMed ID: 23996244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-based analysis of randomized comparison of bioactive versus everolimus-eluting stents in acute coronary syndrome.
    Sia J; Nammas W; Niemelä M; Airaksinen JK; Lalmand J; Laine M; Tedjokusumo P; Nyman K; Biancari F; Karjalainen PP
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):197-203. PubMed ID: 25003998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial.
    Karjalainen PP; Airaksinen JK; de Belder A; Romppanen H; Kervinen K; Sia J; Laine M; Nammas W
    Ann Med; 2016 Aug; 48(5):376-83. PubMed ID: 27238465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Preexisting Vascular Disease on the Outcome of Patients With Acute Coronary Syndrome: Insights From the Comparison of Bioactive Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome Trial.
    Nammas W; Airaksinen JKE; Romppanen H; Sia J; de Belder A; Karjalainen PP
    Angiology; 2017 Jul; 68(6):513-518. PubMed ID: 27543565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial.
    Tonino PAL; Pijls NHJ; Collet C; Nammas W; Van der Heyden J; Romppanen H; Kervinen K; Airaksinen JKE; Sia J; Lalmand J; Frambach P; Penaranda AS; De Bruyne B; Karjalainen PP;
    JACC Cardiovasc Interv; 2020 Jul; 13(14):1697-1705. PubMed ID: 32703593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial.
    Antonsen L; Thayssen P; Hansen HS; Maeng M; Tilsted HH; Bøtker HE; Ravkilde J; Madsen M; Sørensen HT; Thuesen L; Lassen JF; Jensen LO
    EuroIntervention; 2014 Jun; 10(2):212-23. PubMed ID: 23838425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial.
    Brener SJ; Kereiakes DJ; Simonton CA; Rizvi A; Newman W; Mastali K; Wang JC; Caputo R; Smith RS; Ying SW; Cutlip DE; Stone GW
    Am Heart J; 2013 Dec; 166(6):1035-42. PubMed ID: 24268218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial.
    Jensen LO; Thayssen P; Christiansen EH; Tilsted HH; Maeng M; Hansen KN; Kaltoft A; Hansen HS; Bøtker HE; Krusell LR; Ravkilde J; Madsen M; Thuesen L; Lassen JF;
    J Am Coll Cardiol; 2012 Sep; 60(13):1140-7. PubMed ID: 22958957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.
    Varho V; Kiviniemi TO; Nammas W; Sia J; Romppanen H; Pietilä M; Airaksinen JK; Mikkelsson J; Tuomainen P; Perälä A; Karjalainen PP
    Int J Cardiovasc Imaging; 2016 Jul; 32(7):1031-9. PubMed ID: 27076220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of twelve-month outcomes after percutanous coronary intervention with everolimus-eluting versus zotarolimus-eluting or sirolimus-eluting stents from the PROENCY (PROmus ENdeavor CYpher) registry.
    Damman P; Abdel-Wahab M; Möllmann H; Richardt G; Chevalier B; Barragan P; Tijssen JG; Underwood P; Hamm CW
    J Invasive Cardiol; 2012 Oct; 24(10):495-502. PubMed ID: 23043032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial.
    Tuomainen PO; Ylitalo A; Niemelä M; Kervinen K; Pietilä M; Sia J; Nyman K; Nammas W; Airaksinen KE; Karjalainen PP
    J Invasive Cardiol; 2012 Mar; 24(3):104-8. PubMed ID: 22388300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.
    Harjai KJ; Kondareddy S; Pinkosky B; Harjai N; Orshaw P; Boura J
    J Interv Cardiol; 2013 Apr; 26(2):153-62. PubMed ID: 23363439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.